✦ LIBER ✦

LRRK2 as a therapeutic target in Parkinson’s disease

✍ Scribed by E. K. Tan; A. H. Schapira

Book ID: 111066616
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 70 KB
Volume: 18
Category: Article
ISSN: 1351-5101
DOI: 10.1111/j.1468-1331.2010.03305.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PPAR: a therapeutic target in Parkinson’

PPAR: a therapeutic target in Parkinson’s disease

✍ Rajnish K. Chaturvedi; M. Flint Beal 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

Lrrk2pathogenic substitutions in Parkins

Lrrk2pathogenic substitutions in Parkinson's disease

✍ Ignacio F. Mata; Jennifer M. Kachergus; Julie P. Taylor; Sarah Lincoln; Jan Aasl 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 415 KB

LRRK2 in Parkinson’s disease: biochemica

LRRK2 in Parkinson’s disease: biochemical functions

✍ Vasanti S. Anand; Steven P. Braithwaite 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

LRRK2 and Parkinson’s disease in Norway

✍ M. Toft; K. Haugarvoll; O. A. Ross; M. J. Farrer; J. O. Aasly 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

New LRRK2 variants identified in Parkins

New LRRK2 variants identified in Parkinson’s disease

✍ E. K. Tan; A. H. Schapira 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

LRRK2 variation and Parkinson's disease

LRRK2 variation and Parkinson's disease in African Americans

✍ Owen A. Ross; Greggory J. Wilhoite; Justin A. Bacon; Alexandra Soto-Ortolaza; Je 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 639 KB

## Abstract The global impact of __LRRK2__ mutations is yet to be realized with a lack of studies in specific ethnic groups, including those of Asian and African descent. Herein, we investigated the frequency of common __LRRK2__ variants by complete exon sequencing in a series of publicly available